Who
Marc Mazur
Director
Company insider
Files Form 4 as: Director, SuRo Capital; Director, Celularity; Director, Fibrocell Science; Director, Majesco Entertainment Co.
In numbers
- Trades disclosed
- 43
- Buys
- 2
- Sells
- 0
- Bought
- $41K
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 3 May 2006
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | SuRo Capital | SEC FORM 4 Code A | —3,536 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | NSLR Neostellar CapitalFunds, Shells & SPACs | SEC FORM 4 Code A | —3,536 at $0.00 | filing |
| 28 May 2025filed 30 May 2025 | NSLR Neostellar CapitalFunds, Shells & SPACs | SEC FORM 4 Code A | —7,812 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | NSLR Neostellar CapitalFunds, Shells & SPACs | SEC FORM 4 Code A | —12,048 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code A | —277,778 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —199,921 at $0.00 | filing |
| 31 May 2023filed 2 Jun 2023 | NSLR Neostellar CapitalFunds, Shells & SPACs | SEC FORM 4 Code A | —15,015 at $0.00 | filing |
| 13 Jul 2022filed 15 Jul 2022 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,152 at $0.00 | filing |
| 13 Jul 2022filed 15 Jul 2022 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —36,145 at $0.00 | filing |
| 1 Jun 2022filed 3 Jun 2022 | NSLR Neostellar CapitalFunds, Shells & SPACs | SEC FORM 4 Code A | —6,684 at $0.00 | filing |
| 9 Sep 2021filed 13 Sep 2021 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code A | —56,053 at $0.00 | filing |
| 9 Jul 2021filed 13 Jul 2021 | NSLR Neostellar CapitalFunds, Shells & SPACs | SEC FORM 4 Code A | —3,770 at $0.00 | filing |
| 2 Jul 2020filed 2 Jul 2020 | NSLR Neostellar CapitalFunds, Shells & SPACs | SEC FORM 4 Code A | —5,440 at $0.00 | filing |
| 13 Dec 2019filed 13 Dec 2019 | Fibrocell Scienceoption or derivative | SEC FORM 4 Code D | —534 | filing |
| 13 Dec 2019filed 13 Dec 2019 | Fibrocell Scienceoption or derivative | SEC FORM 4 Code D | —534 | filing |
| 13 Dec 2019filed 13 Dec 2019 | Fibrocell Scienceoption or derivative | SEC FORM 4 Code D | —534 | filing |
| 13 Dec 2019filed 13 Dec 2019 | Fibrocell Scienceoption or derivative | SEC FORM 4 Code D | —1,600 | filing |
| 13 Dec 2019filed 13 Dec 2019 | Fibrocell Scienceoption or derivative | SEC FORM 4 Code D | —1,200 | filing |
| 13 Dec 2019filed 13 Dec 2019 | Fibrocell Scienceoption or derivative | SEC FORM 4 Code D | —2,400 | filing |
| 13 Dec 2019filed 13 Dec 2019 | Fibrocell Scienceoption or derivative | SEC FORM 4 Code D | —2,400 | filing |
News
Neostellar Capital (NASDAQ:NSLR) vs. PayPal (NASDAQ:PYPL) Critical SurveyNSLR · themarketsdaily.com · 14 Oct 2026Reviewing Freedom (NASDAQ:FRHC) and Neostellar Capital (NASDAQ:NSLR)NSLR · tickerreport.com · 12 Oct 2026Comparing Fiserv (NASDAQ:FISV) & Neostellar Capital (NASDAQ:NSLR)NSLR · dailypolitical.com · 6 Oct 2026
0 headlines in the last 90 days name Marc Mazur; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.